Vitamin D as a predictor of clinical response among patients with cardiac resynchronization therapy (CRT)

Phuuwadith Wattanachayakul1,2, Thitiphan Srikulmontri1,2, Vitchapong Prasitsumrit3

  • 1Department of Medicine Jefferson Einstein Hospital Philadelphia Pennsylvania USA.

Journal of Arrhythmia
|August 14, 2024
PubMed

Insights

Higher vitamin D levels predict better response to cardiac resynchronization therapy (CRT). Vitamin D insufficiency increases the risk of nonresponse to CRT, highlighting the need for monitoring and management in patients undergoing this therapy.

Area of Science:

  • Cardiology
  • Endocrinology
  • Nutritional Science

Background:

  • Comorbidities impact cardiac resynchronization therapy (CRT) response.
  • Previous data on vitamin D as a predictor of CRT response are conflicting.

Purpose of the Study:

  • To investigate the association between pre-implantation 25-OH vitamin D levels and outcomes in patients receiving CRT.
  • To clarify the role of vitamin D status in predicting CRT response.

Main Methods:

  • A meta-analysis of four studies identified through MEDLINE and Embase searches (up to May 2024).
  • Extracted 25-OH vitamin D levels and CRT response data.
  • Calculated pooled mean difference for vitamin D levels and risk ratios for vitamin D insufficiency and lack of CRT response.

Main Results:

  • CRT responders exhibited significantly higher 25-OH vitamin D levels (pooled MD: 8.04 ng/mL).
  • Vitamin D insufficiency was associated with a 3.28-fold increased odds of lacking response to CRT (pooled RR: 3.28).

Conclusions:

  • Higher pre-implantation 25-OH vitamin D levels are linked to positive CRT response.
  • Vitamin D insufficiency is a significant risk factor for nonresponse to CRT.
  • Monitoring and managing vitamin D levels may optimize CRT outcomes.
Abstract